CD74 and colorectal cancer: We further validated this potential reprogramming using spatial transcriptomic profiles of primary tumor samples from colorectal cancer patients, consistently observed significant negative correlations between SPP1 and CD74 expression within immune cells-enriched region (e.g., tertiary lymphoid structures) (Fig. 4j, k, and Supplementary Fig. 8a–e)51.